“There is something called bioethics that is probably the least ethical thing on the planet right now.”–Elizabeth Parrish
Welcome to the second year of the Seeking Delphi™ podcast. We eneded 2017 with Part One of Ending Aging, featuring an interview with the author of Ending Aging, SENS foundation Chief Science Officer, Aubrey de Grey. 2018 kicks off with part two of Ending Aging, featuring Bioviva CEO, Elizabeth Parrish. In 2015 she became the first person ever to receive genetic editing therapies to reverse some aspects of biological aging. Her comments–especially the one above–are well worth the while of anyone with interest in the subject.
Links to relevant stories appear after the audio file and embedded YouTube video below. A reminder that this and all Seeking Delphi ™podcasts are available on iTunes, PlayerFM, and has a channel on YouTube. You can also follow us on Facebook and on twitter @MarkSackler
Episode #20. Ending Aging, Part Two, with Elizabeth Parrish
YouTube slide show of Episode #20
And in case you missed it, ending aging, Part 1, with Aubrey de Grey
Relevant links
Ending Aging, by Aubrey de Grey, on Amazon
The Abolition of Aging, by David Wood, on Amazon
Elizabeth Parrish self-tests Bioviva gene therapy
George Church’s ambitious plans
Subscribe to Seeking Delphi™ on iTunes
Subscribe to Seeking Delphi™ on PlayerFM
Subscribe on YouTube
Follow Seeking Delphi™ on Facebook @SeekingDelphi
Follow me on twitter @MarkSackler
Even as Trumpism continues to agitate and divide the U.S., Brexit continues to do the same in Britain. As the process plays out through lengthy and difficult negotiations, no particular outcome is clear. In this podcast episode #18 of Seeking Delphi™, I talk with one of the architects of SAMI Consulting’s wide ranging report on 4 possible scenarios for Brexit, through 2030. The future is murky, but one way or the other, it will get here.
Groff, who joins me as my guest on this episode of Seeking Delphi.™
Seeking Delphi™ 